Clinical Trial Detail

NCT ID NCT02113878
Title Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and Neck
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

larynx cancer

hypopharynx cancer

nasopharynx carcinoma

head and neck cancer

Therapies

Buparlisib + Cisplatin

Age Groups: adult

No variant requirements are available.